Clinical Trial Update: Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial in metastatic melanoma evaluates lymphodepletion followed by adoptive cell transfer, with or without dendritic cell immunization, to as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Adoptive cell transfer (adoptive cell transfer)
• Dendritic cell immunization (dendritic cell immunization)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Melanoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING